46.81
Scholar Rock Holding Corp Aktie (SRRK) Neueste Nachrichten
Investigation launched into Scholar Rock's offi... - Pluang
Kuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm - TradingView
Scholar Rock Holding Corp. Cash Flow – HAN:2QK - TradingView
Net income of Scholar Rock Holding Corp. – HAN:2QK - TradingView
EBIT of Scholar Rock Holding Corp. – HAN:2QK - TradingView
SRRK Stock Gains After Company Drops Troubled Novo Nordisk-Owned Plant From FDA Filing - Stocktwits
Form 4 Scholar Rock Holding Corp For: 26 September By Investing.com - Investing.com Canada
No common shares appear in Scholar Rock (SRRK) COO Keith Woods’s reported position after a gift to a trust. - Stock Titan
Scholar Rock Holding Corp (SRRK) Gains Wedbush Spotlight Amid Valuation and Insider Activity Insights - GuruFocus
Scholar Rock added to Wedbush's Best Ideas List - Seeking Alpha
Piper Sandler reiterates Scholar Rock stock rating on uptake view By Investing.com - Investing.com Australia
Wedbush Rates Scholar Rock (SRRK) Outperform Amid Attractive Pri - GuruFocus
Piper Sandler reiterates Scholar Rock stock rating on uptake view - Investing.com
symbol__ Stock Quote Price and Forecast - CNN
SRRK Maintains Buy Rating by Truist Securities -- Price Target R - GuruFocus
Truist raises Scholar Rock stock price target on drug pricing update By Investing.com - Investing.com Australia
Truist raises Scholar Rock stock price target on drug pricing update - Investing.com
Truist Lifts Price Target on Scholar Rock Holding to $77 From $76, Keeps Buy Rating - Yahoo Finance
Scholar Rock (SRRK) Short Interest & Short Float | Updated Sep 2026 $SRRK - MarketBeat
No payment changed hands when Scholar Rock (SRRK) CEO David Hallal transferred 36,652 shares to a family trust. - Stock Titan
Scholar Rock’s Isembyld approval sets up rapid sales ramp - S&P Global
Scholar Rock Holding Corporation (SRRK) stock price, news, quote and history - Yahoo Finance UK
Scholar Rock Holding Corporation (SRRK) Stock Price, News, Quote & History - Yahoo! Finance Canada
Scholar Rock (NASDAQ:SRRK) Shares Up 6% Following Analyst Upgrade - MarketBeat
Weight-loss drug developers line up to tap lucrative market as competition heats up - reuters.com
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Database
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
SRRK Maintains Overweight Rating by JP Morgan -- Price Target Ra - GuruFocus
Scholar Rock (NASDAQ:SRRK) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says - MarketBeat
JPMorgan raises Scholar Rock stock price target to $70 on launch outlook - Investing.com Nigeria
Bank of America Corp DE Takes $53.47 Million Position in Scholar Rock Holding Corporation $SRRK - MarketBeat
Scholar Rock Holding (SRRK) Won FDA Approval, Is The Stock Still Trading At A Discount? - Simply Wall Street
Scholar Rock (NASDAQ:SRRK) Raised to Strong-Buy at Jefferies Financial Group - MarketBeat
HC Wainwright Lowers Earnings Estimates for Scholar Rock - MarketBeat
Scholar Rock Holding (SRRK) Wins FDA Approval for ISEMBYLD. Can Add-On Use Scale? - Insider Monkey
Scholar Rock (NASDAQ: SRRK) Updates FDA Safety Requirements for ISEMBYLD Post-Approval - Kalkine Media
Scholar Rock (SRRK) Stock Fair Value Edges Higher After Isembyld Approval And Analyst Revisions - Yahoo Finance
Piper Sandler raises Scholar Rock stock price target on pricing By Investing.com - Investing.com South Africa
Scholar Rock (SRRK) Gains FDA Approval for Isembyld Amid Post-Ma - GuruFocus
Scholar Rock Shares Fall After Barclays Downgrade - marketscreener.com
Scholar Rock Faces Early Isembyld Launch Friction From FDA Safety Requirements, Truist Says - marketscreener.com
Scholar Rock (SRRK) Shares Drop Amid Barclays Downgrade Despite FDA Approval - GuruFocus
Scholar Rock clarifies post-marketing requirements for ISEMBYLD after FDA approval - Investing.com
Scholar Rock (NASDAQ:SRRK) Shares Down 7.1%Here's What Happened - MarketBeat
Form 8K Scholar Rock Holding Corp For: 15 September By Investing.com - Investing.com Australia
SRRK Maintained by Wedbush -- Price Target Raised to $70 - GuruFocus
UBS reiterates Buy on Scholar Rock stock, keeps $60 price target - Investing.com
Scholar Rock Updates FDA Post-Marketing Safety Requirements for ISEMBYLD Following Investor Call Correction - kalkinemedia.com
H.C. Wainwright raises Scholar Rock stock price target on FDA approval - Investing.com UK
SRRK Maintained by HC Wainwright & Co. -- Price Target Raised to $70 - GuruFocus
Barclays downgrades Scholar Rock stock rating on valuation By Investing.com - Investing.com Australia
Barclays Downgrades Scholar Rock to Equalweight From Overweight, Adjusts PT to $58 From $55 - marketscreener.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):